跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
compound 194
首页
药物
compound 194
compound 194
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Methods, Agents, and Compound Screening Assays for Inducing Differentiation of Undifferentiated Mammalian Cells into Osteoblasts
US 2007184026 A1
申请人: GALAPAGOS NV
优先权: 2004
US
6 件公开
Methods for identifying compounds which modulate hematopoiests
US 7250262 B2
申请人: BAYERHEALTH CARE AG
优先权: 2003
US
2 件公开
Diphenylimidazole-fused, spirally configured cis-stilbene/fluorene hybrid compounds and organic light emitting device comprising the same
US 10186667 B2
申请人: NICHEM FINE TECH CO LTD
优先权: 2016
US
2 件公开
Choline Salt Crystal of Azulene Compound
US 2009182039 A1
申请人: IMAMURA MASAKAZU
优先权: 2005
US
Novel synthetic method for flavonoid compound
CN 105585545 A
申请人: CHEN YUMEI
优先权: 2014
CN
Cefminox sodium compound, cefminox sodium for injection and preparation method
CN 105713014 A
申请人: ZHANG CHUNYAN
优先权: 2016
CN
Synthesis of AZO intermediate
US 10131638 B1
申请人: US NAVY
优先权: 2018
US
Cottonseed protein source ACE (angiotensin converting enzyme) inhibitory peptide as well as screening and modifying method and application thereof
CN 122277651 A
申请人: UNIV ZHENGZHOU LIGHT IND
优先权: 2026
CN
药物
反馈